Trial intelligence / Profile preview

VivaGel (SPL7013) Retention and Antiviral Activity in Healthy Volunteers

NCT00740584Phase 2Completed

Sponsor
Starpharma
Start
Aug 2008
Primary completion
Mar 2009
Countries
1
01

Overview

A Phase 2 trial of astodrimer in human immunodeficiency virus infection (HIV), Herpes Simplex Virus Type 2 Infection (HSV-2), sponsored by Starpharma. Started Aug 2008; status: completed.

02

Drugs

astodrimer
03

Conditions

human immunodeficiency virus infection (HIV)Herpes Simplex Virus Type 2 Infection (HSV-2)

Beyond the preview

Go deeper on NCT00740584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00740584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call